Risk factors associated with false negative rate of sentinel lymph node biopsy in endometrial cancer: a systematic review and meta-analysis
ObjectiveCurrently, sentinel lymph node biopsy (SLNB) is increasingly used in endometrial cancer, but the rate of missed metastatic lymph nodes compared to systemic lymph node dissection has been a concern. We conducted a systematic review and meta-analysis to evaluate the false negative rate (FNR)...
Main Authors: | Meng-si Fan, Ke-xin Qiu, Dong-yue Wang, Hao Wang, Wei-wei Zhang, Li Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1391267/full |
Similar Items
-
Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues
by: Yoo-Na Kim, et al.
Published: (2022-09-01) -
Visualization Methods for Uterine Sentinel Lymph Nodes in Early-Stage Endometrial Carcinoma: A Comparative Analysis
by: Linas Andreika, et al.
Published: (2024-03-01) -
SENTINEL LYMPH NODES IN ENDOMETRIAL CANCER
by: A. I. Berishvili, et al.
Published: (2017-06-01) -
Sentinel lymph nodes biopsy in the surgical treatment of endometrial cancer: history and present
by: M. O. Ochirov, et al.
Published: (2019-02-01) -
The Feasibility of Sentinel Lymph-Node, Mapped with Indocyanine Green, Biopsy in Endometrial Cancer Patients: A Prospective Study
by: Migle Gedgaudaite, et al.
Published: (2022-05-01)